Sports Ventures Acquisition Equity Warrant Exp 06 Jan 2028 *W EXP 01/06/2028
Change company Symbol lookup
Select an option...
AKICW Sports Ventures Acquisition Equity Warrant Exp 06 Jan 2028 *W EXP 01/06/2028
AZTA Azenta Inc
TSLX Sixth Street Specialty Lending Inc
PPG PPG Industries Inc
SP SP Plus Corp
RHCGF Ryman Healthcare Ltd
CSCO Cisco Systems Inc
UTZ UTZ Brands Inc
BSQR Bsquare Corp
APYX Apyx Medical Corp
Go

Company profile

Sports Ventures Acquisition Corp. is a blank check company. The Company is formed for the purpose of effecting a merger, share exchange, asset acquisition, share purchase, reorganization or other similar business combination. The Company may pursue acquisitions in any sector or industry. The Company intends to search for opportunities in the sports, media and entertainment sectors, including traditional and emerging sports as well as film and television production and infrastructure.

Price
Delayed
$0.0696
Day's Change
-0.0072 (-9.38%)
Bid
--
Ask
--
B/A Size
--
Day's High
0.0696
Day's Low
0.0696
Volume
(Light)

Today's volume of 100 shares is on pace to be much lighter than AKICW's 10-day average volume of 23,424 shares.

100

The Gross Law Firm Announces Class Actions on Behalf of Shareholders of AMZN, OSCR and AXSM

11:11 am ET May 20, 2022 (Accesswire) Print

NEW YORK, NY / ACCESSWIRE / May 20, 2022 / The securities litigation law firm of The Gross Law Firm issues the following notice on behalf of shareholders in the following publicly traded companies. Shareholders who purchased shares in the following companies during the dates listed are encouraged to contact the firm regarding possible Lead Plaintiff appointment. Appointment as Lead Plaintiff is not required to partake in any recovery.

Amazon.com, Inc. (NASDAQ:AMZN)

Investors Affected : February 1, 2019 - April 5, 2022

A class action has commenced on behalf of certain shareholders in Amazoncom, Inc. The filed complaint alleges that defendants made materially false and/or misleading statements and/or failed to disclose that: (i) Amazon engaged in anticompetitive conduct in its private-label business practices, including giving Amazon products preference over those of its competitors and using third-party sellers' non-public data to compete with them; (ii) the foregoing exposed Amazon to a heightened risk of regulatory scrutiny and/or enforcement actions; (iii) Amazon's revenues derived from its private-label business were in part the product of impermissible conduct and thus unsustainable; and (iv) as a result, the defendants' public statements throughout the class period were materially false and/or misleading.

Shareholders may find more information at https://securitiesclasslaw.com/securities/amazon-com-inc-loss-submission-form/?id=27529&from=1

Oscar Health, Inc. (NYSE:OSCR)

This lawsuit is on behalf of persons and entities that purchased or otherwise acquired Oscar Class A common stock pursuant and/or traceable to the registration statement and prospectus issued in connection with the Company's March 2021 initial public offering.

A class action has commenced on behalf of certain shareholders in Oscar Health, Inc. The filed complaint alleges that defendants made materially false and/or misleading statements and/or failed to disclose that: (1) Oscar was experiencing growing COVID-19 testing and treatment costs; (2) Oscar was experiencing growing net COVID costs; (3) Oscar would be negatively impacted by an unfavorable prior year Risk Adjustment Data Validation result relating to 2019 and 2020; (4) Oscar was on track to be negatively impacted by significant SEP membership growth; and (5) as a result of the foregoing, defendants' positive statements about the Company's business, operations, and prospects were materially misleading and/or lacked a reasonable basis.

Shareholders may find more information at https://securitiesclasslaw.com/securities/oscar-health-inc-loss-submission-form/?id=27529&from=1

Axsome Therapeutics, Inc. (NASDAQ:AXSM)

Investors Affected : December 30, 2019 - April 22, 2022

A class action has commenced on behalf of certain shareholders in Axsome Therapeutics, Inc. The filed complaint alleges that defendants made materially false and/or misleading statements and/or failed to disclose that: (i) Axsome's chemistry, manufacturing, and control ("CMC") practices were deficient with respect to AXS-07, the Company's medicine for the acute treatment of migraine, and its manufacturing process; (ii) as a result, Axsome was unlikely to submit the AXS-07 New Drug Application ("NDA") on its initially represented timeline; (iii) the foregoing CMC issues remained unresolved at the time that the U.S. Food and Drug Administration ("FDA") reviewed the AXS-07 NDA; (iv) accordingly, the FDA was unlikely to approve the AXS-07 NDA; (v) as a result of all the foregoing, Axsome had overstated AXS-07's regulatory and commercial prospects; and (vi) as a result, the Company's public statements were materially false and misleading at all relevant times.

Shareholders may find more information at https://securitiesclasslaw.com/securities/axsome-therapeutics-inc-loss-submission-form/?id=27529&from=1

The Gross Law Firm, Friday, May 20, 2022, Press release picture

The Gross Law Firm is committed to ensuring that companies adhere to responsible business practices and engage in good corporate citizenship. The firm seeks recovery on behalf of investors who incurred losses when false and/or misleading statements or the omission of material information by a Company lead to artificial inflation of the Company's stock. Attorney advertising. Prior results do not guarantee similar outcomes.

CONTACT:

The Gross Law Firm

15 West 38th Street, 12th floor

New York, NY, 10018

Email: dg@securitiesclasslaw.com

Phone: (212) 537-9430

Fax: (833) 862-7770

SOURCE: The Gross Law Firm





View source version on accesswire.com:

https://www.accesswire.com/702154/The-Gross-Law-Firm-Announces-Class-Actions-on-Behalf-of-Shareholders-of-AMZN-OSCR-and-AXSM



comtex tracking

COMTEX_407509831/2457/2022-05-20T11:11:10

Earnings Calendar and Events Data provided by |Terms of Use| © 2022 Wall Street Horizon, Inc.

Market data accompanied by is delayed by at least 15 minutes for NASDAQ, NYSE MKT, NYSE, and options. Duration of the delay for other exchanges varies.
Market data and information provided by Morningstar.

Options are not suitable for all investors as the special risks inherent to options trading may expose investors to potentially rapid and substantial losses.
Please read Characteristics and Risks of Standard Options before investing in options.

Information and news provided by ,, , Computrade Systems, Inc., ,, and

Copyright © 2022. All rights reserved.